Diseases, Noncommunicable

Transcript

Scalable Strategies for Non-Communicable Diseases in Developing Countries

Speakers: James Habyarimana, Matthew L. Myers, and Bernhard Weigl
Presider: Thomas J. Bollyky

James Habyarimana, Matthew L. Myers, and Bernhard Weigl discuss scalable and practical strategies developing countries can use to address the global health challenges of noncommunicable diseases. This session is part two of the two session meeting, Noncommunicable Diseases and the New Global Health.

See more in Global; Diseases, Noncommunicable; Health Policy and Initiatives

Audio

The Rise of NCDs in Low- and Middle-Income Countries (Audio)

Speaker: Thomas R. Frieden
Presider: Jo Ivey Boufford

Thomas R. Frieden, director of U.S. Centers for Disease Control and Prevention and administrator of the Agency for Toxic Substances and Disease Registry, discusses the challenges facing low- and middle-income countries in combating noncommunicable diseases.

This session is part one of the two session meeting, Noncommunicable Diseases and the New Global Health.

See more in Diseases, Noncommunicable; Global

Backgrounder

Global Action on Non-Communicable Diseases

Author: Toni Johnson

NCDs such as cancer and heart disease are becoming leading causes of death in the developing world and will be the focus of a September UN meeting. But health experts and others are divided about how much funding should go into a global campaign aimed at preventing NCDs and whether infectious disease programs will suffer as a result.

See more in Diseases, Noncommunicable; Global

Video

Prioritizing Non-Communicable Diseases

Interviewer: Toni Johnson
Interviewee: Derek Yach

Derek Yach, director of global health policy at PepsiCo, discusses the role of government and business in lowering mortality rates from non-communicable diseases (NCDs). "We now have overwhelming evidence, both of the health impact, and perhaps as importantly, we're starting to see the economic impact of heart disease, diabites, chronic lung disease, cancer," says Yach, arguing this data is raising global interest in the issue of NCDs.

See more in Diseases, Noncommunicable; Global